Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Alcohol Liver Disease
77%
Wilson's Disease
54%
Portal Hypertension
51%
Fibrosis
34%
Copper 64
33%
Mannose Receptor
33%
Normal Human
32%
Antiviral Therapy
29%
Liver Disease
29%
Chronic Hepatitis C
28%
Disease
26%
Antivirus Agent
22%
Alagille Syndrome
16%
CD18 Antigen
16%
Penicillamine
16%
Trientine
16%
Disease Severity
14%
Inflammation
14%
Liver Fibrosis
13%
Hepatitis
12%
Ethanol
11%
Hepatitis C
10%
Biodistribution
10%
Tracer
10%
Prevalence
10%
Infection
10%
Placebo
9%
Event Free Survival
9%
Lipopolysaccharide
9%
Bilirubin
9%
Clinical Trial
9%
Clinical Study
9%
Biliary Excretion
9%
Disease Course
8%
Human Serum Albumin
8%
Liver Cell Carcinoma
8%
Retinol Binding Protein 4
8%
Iron Poisoning
8%
Maralixibat
8%
Adiponectin
8%
Cohort Study
8%
Tetrathiomolybdic Acid
8%
Branched Chain Amino Acid
8%
Dosimetry
8%
Interleukin 22
8%
Adipocytokine
8%
End Stage Liver Disease
8%
Hemochromatosis
8%
Chronic Hepatitis B
8%
Medicine and Dentistry
Liver Cirrhosis
59%
Wilson's Disease
44%
Liver Disease
44%
Alcohol Liver Disease
41%
Macrophage Activation
31%
Fibrosis
30%
Antiviral Therapy
27%
Disease
24%
Chronic Hepatitis C
24%
Portal Hypertension
22%
Disease Course
19%
Gut
17%
Glycon
16%
Alagille Syndrome
16%
Copper 64
16%
Bacterial Translocation
16%
Mannose Receptor
16%
Liver Fibrosis
13%
Liver Function
11%
Combination Therapy
11%
Hepatitis
11%
Treatment Response
11%
Galactose
11%
Child-Pugh Score
10%
Event Free Survival
9%
Clinical Trial
9%
Placebo
9%
Radioactive Tracer
9%
Infection
9%
Portal Venous Pressure
8%
Cytokine
8%
Clinical Study
8%
Kayser-Fleischer Ring
8%
Hepatocellular Carcinoma
8%
Receptor Expression
8%
Pediatrics
8%
Radiofrequency Ablation
8%
Exon
8%
Meal
8%
Maralixibat
8%
Patient with Type 2 Diabetes
8%
Hemochromatosis
8%
Transcatheter Arterial Chemoembolization
8%
Lactic Acid
8%
Protein Binding
8%
Venous Pressure
8%
Cohort Analysis
8%
Cohort Effect
8%
Liver Abscess
8%
Klebsiella pneumoniae
8%
Immunology and Microbiology
CD163
61%
Macrophage Activation
39%
Mannose Receptor
33%
Macrophage
30%
Normal Human
26%
Urea Cycle
24%
Blood Level
22%
Monocyte
22%
Ficolin
20%
Mannan-Binding Lectin
20%
Hepatitis C
17%
Positron Emission Tomography
16%
Bacterial Translocation
16%
ELISA
16%
Tumor Necrosis Factor
16%
Interleukin 22
13%
Lectin Pathway
11%
Blood Plasma
11%
Infectious Agent
11%
Liver Function
11%
Collectin
10%
Kupffer Cell
9%
Complement System
9%
Autoimmune Hepatitis
9%
Lipopolysaccharide Binding Protein
8%
Hepatitis B
8%
CD14
8%
Interferon Type I
8%
Amino Acid Blood Level
8%
Serum (Blood)
8%
Crohn's Disease
8%
Transjugular Intrahepatic Portosystemic Shunt
8%
Systemic Inflammation
8%
Somatomedin C
8%
Hepatic Portal Vein
8%
Heavy Chain
8%
TLR4
8%
Mortality Rate
8%
CD18
8%
T Helper Cell
8%
Muscle Metabolism
8%
Copper Blood Level
8%
Short Term Survival
6%
Liver Tissue
6%
X-Ray Computed Tomography
6%
Single Nucleotide Polymorphism
5%
Heterozygote
5%
Interleukin-1
5%
Primary Biliary Cirrhosis
5%
